0000905148-21-000431.txt : 20210505
0000905148-21-000431.hdr.sgml : 20210505
20210505181848
ACCESSION NUMBER: 0000905148-21-000431
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210503
FILED AS OF DATE: 20210505
DATE AS OF CHANGE: 20210505
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vazquez Martin
CENTRAL INDEX KEY: 0001823380
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39513
FILM NUMBER: 21894993
MAIL ADDRESS:
STREET 1: 3052 ORCHARD DR.
CITY: SAN JOSE
STATE: CA
ZIP: 95134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Outset Medical, Inc.
CENTRAL INDEX KEY: 0001484612
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 200514392
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 3052 ORCHARD DRIVE
CITY: SAN JOSE
STATE: CA
ZIP: 95134
BUSINESS PHONE: 669-231-8200
MAIL ADDRESS:
STREET 1: 3052 ORCHARD DRIVE
CITY: SAN JOSE
STATE: CA
ZIP: 95134
FORMER COMPANY:
FORMER CONFORMED NAME: Home Dialysis Plus, Ltd.
DATE OF NAME CHANGE: 20100219
4
1
form4.xml
X0306
4
2021-05-03
0001484612
Outset Medical, Inc.
OM
0001823380
Vazquez Martin
3052 ORCHARD DRIVE
SAN JOSE
CA
95134
true
Chief Operating Officer
Common Stock
2021-05-03
4
M
0
2932
3.88
A
12187
D
Common Stock
2021-05-03
4
M
0
2068
3.88
A
14255
D
Common Stock
2021-05-03
4
S
0
4224
57.8896
D
10031
D
Common Stock
2021-05-03
4
S
0
539
58.8242
D
9492
D
Common Stock
2021-05-03
4
S
0
237
59.8059
D
9255
D
Performance Stock Option (Right to Buy)
3.88
2021-05-03
4
M
0
2932
0
D
2018-12-21
2027-12-19
Common Stock
2932
0
D
Stock Option (Right to Buy)
3.88
2021-05-03
4
M
0
2068
0
D
2027-12-19
Common Stock
2068
89489
D
The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $57.46 to $58.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1).
The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $58.48 to $58.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).
The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $59.77 to $60.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3).
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020.
This option vests 25% on October 9, 2018 and then in 36 monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting period.
/s/ John L. Brottem, attorney-in-fact for Martin Vazquez
2021-05-05